Cargando…
Changes in Metabolism as a Diagnostic Tool for Lung Cancer: Systematic Review
Lung cancer is the leading cause of cancer-related mortality worldwide, with five-year survival rates varying from 3–62%. Screening aims at early detection, but half of the patients are diagnosed in advanced stages, limiting therapeutic possibilities. Positron emission tomography-computed tomography...
Autores principales: | Mariën, Hanne, Derveaux, Elien, Vanhove, Karolien, Adriaensens, Peter, Thomeer, Michiel, Mesotten, Liesbet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229104/ https://www.ncbi.nlm.nih.gov/pubmed/35736478 http://dx.doi.org/10.3390/metabo12060545 |
Ejemplares similares
-
Unraveling the Rewired Metabolism in Lung Cancer Using Quantitative NMR Metabolomics
por: Vanhove, Karolien, et al.
Publicado: (2022) -
Correlations between the metabolic profile and (18)F-FDG-Positron Emission Tomography-Computed Tomography parameters reveal the complexity of the metabolic reprogramming within lung cancer patients
por: Vanhove, Karolien, et al.
Publicado: (2019) -
The Metabolic Landscape of Lung Cancer: New Insights in a Disturbed Glucose Metabolism
por: Vanhove, Karolien, et al.
Publicado: (2019) -
Glutamine Addiction and Therapeutic Strategies in Lung Cancer
por: Vanhove, Karolien, et al.
Publicado: (2019) -
Detection of Lung Cancer via Blood Plasma and (1)H-NMR Metabolomics: Validation by a Semi-Targeted and Quantitative Approach Using a Protein-Binding Competitor
por: Derveaux, Elien, et al.
Publicado: (2021)